Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$451K Buy
11,847
+833
+8% +$29.6K 0.01% 555
2026
Q1
$330K Buy
11,014
+432
+4% +$13.7K 0.01% 596
2025
Q4
$309K Buy
10,582
+154
+1% +$4.08K 0.01% 601
2025
Q3
$272K Sell
10,428
-1,321
-11% -$32.8K 0.01% 624
2025
Q2
$265K Sell
11,749
-856
-7% -$17.6K 0.01% 605
2025
Q1
$263K Buy
+12,605
New +$264K 0.01% 592
2024
Q4
Sell
-9,720
Closed -$226K 537
2024
Q3
$226K Sell
9,720
-10
-0.1% -$235 0.02% 493
2024
Q2
$217K Buy
9,730
+105
+1% +$2.24K 0.02% 481
2024
Q1
$212K Buy
+9,625
New +$196K 0.02% 479

Other funds holding IX

Ascent Group's IX Position: Q2 2026 in Review

Ascent Group increased its ORIX (IX) stake by 7.6% in Q2 2026, buying an estimated $29.6K and bringing the position to 11,847 shares worth $451K. The position accounts for 0.01% of the portfolio, ranked #555.

Ascent Group first reported a position in IX in Q1 2024 and has held it in 9 quarters since. 320 funds tracked by Wall St. Rank hold IX as of Q2 2026.

  • Ascent Group held 11,847 shares of ORIX worth $451K as of Q2 2026.
  • Ascent Group bought 833 ORIX shares in Q2 2026, an estimated $29.6K.
  • ORIX made up 0.01% of Ascent Group's portfolio in Q2 2026, its #555 holding.
  • Ascent Group first reported a position in ORIX in Q1 2024 and has held it in 9 quarters since.
  • 320 funds tracked by Wall St. Rank held ORIX as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.